Altered bone remodeling in psoriatic arthritis
- 1 August 2008
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 10 (4) , 311-317
Abstract
Bone is a highly dynamic organ that interacts with a wide array of cells and tissues. Recent studies have unveiled unanticipated connections between the immune and skeletal systems, and this relationship led to the development of a new field called osteoimmunology. This field will enable investigators to translate basic science findings in bone biology to clinical applications for inflammatory joint diseases such as psoriatic arthritis (PsA). This review examines the disruption of bone homeostasis in PsA and discusses the pivotal role of osteoclasts, osteoblasts, and signaling pathways in the altered remodeling observed in this inflammatory arthritis. It also discusses the effects of tumor necrosis factor inhibition on bone resorption and new bone formation in PsA.Keywords
This publication has 45 references indexed in Scilit:
- The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritisAnnals of the Rheumatic Diseases, 2008
- Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2Arthritis & Rheumatism, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Osteoclasts: What Do They Do and How Do They Do It?The American Journal of Pathology, 2007
- Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trialArthritis & Rheumatism, 2005
- Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsNature, 2005
- Macrophage fusionJournal of Experimental Medicine, 2005
- Osteoclast differentiation and activationNature, 2003
- Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitorsAnnals of the Rheumatic Diseases, 2002
- Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesisJournal of Biological Chemistry, 2000